ClinicalTrials.Veeva

Menu

Revealing Increased Axonal Loss in Treated HIV Patients (OCTIHIV)

F

Fondation Ophtalmologique Adolphe de Rothschild

Status

Completed

Conditions

HIV Seropositivity

Treatments

Other: ophthalmologic examination and MRI

Study type

Observational

Funder types

NETWORK

Identifiers

NCT02003989
RBM_CLL_2012-7

Details and patient eligibility

About

HIV patients may suffer sooner from aging than average population, including brain aging. Our hypothesis is that if brain dysfunctions are explained by a quicker loss of neurons in HIV patients, this loss could be detected earlier by a thinning down of retinal nerve fiber layer (RNFL), compared to non HIV patients of the same age.

Full description

The investigators aim to compare the thickness of the RNFL and the thickness of the RCGs measured by spectral domain OCT between patients infected by HIV and patients of same age non infected by HIV.

Enrollment

156 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • HIV infection known since at least 10 years
  • viral load undetectable under ARV treatment since at least 5 years, whatever the type of ARV
  • lymphocytes CD4 > 350, whatever the CD4 nadir
  • signed informed consent

Exclusion criteria

  • History of ocular pathology, eye surgery, or intraocular injection
  • Familial History of glaucoma
  • ametropia (>3 dioptres on the sphere and >1,5 dioptres on the cylinder)
  • known neurological pathology, active or former
  • History of ethambutol or synthetic antimalarial drug consumption
  • History of chemotherapy
  • Active and regular use of drugs
  • non-weaned chronic alcoholism
  • contra indication to MRI
  • diabetes
  • cognitive disorders (MoCA<26)
  • non covered by health insurance
  • patient under legal protection
  • pregnant or breast-feeding woman
  • Non inclusion criteria for control patients: known HIV infection

Trial design

156 participants in 2 patient groups

patients
Description:
HIV patients infected for more than ten years with undetectable viral load, undergoing ophthalmologic examination and MRI
Treatment:
Other: ophthalmologic examination and MRI
control
Description:
non HIV patients (same gender and age) undergoing ophthalmologic examination and MRI
Treatment:
Other: ophthalmologic examination and MRI

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems